May 9 Sierra Oncology Inc
* Sierra Oncology reports first quarter 2017 results
* Sierra Oncology Inc - qtrly net loss per share $0.26
* Q1 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S
* Sierra Oncology - believes its existing cash and cash equivalents will be sufficient to fund current operating plans through approximately mid-2019 Source text for Eikon: Further company coverage:
Billionaire Buffett throws lifeline to cash-starved Home Capital
June 22 Warren Buffett has again ridden to the rescue of an embattled company in desperate need of a vote of confidence.